LCM
PLRX icon

Landscape Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Landscape Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,146
Closed -$292K – 935
2023
Q4 		$292K Buy
+16,146
New +$246K 0.03% 575
2023
Q2 		– Sell
-20,712
Closed -$551K – 679
2023
Q1 		$551K Sell
20,712
-4,417
-18% -$126K 0.08% 221
2022
Q4 		$486K Buy
+25,129
New +$525K 0.07% 268

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Landscape Capital Management's PLRX Position: Q1 2024 in Review

Landscape Capital Management sold out of Pliant Therapeutics (PLRX) in Q1 2024, closing a stake of 16,146 shares — an estimated $292K sold.

Landscape Capital Management first reported a position in PLRX in Q4 2022 and held it in 3 quarters. The position peaked at $551K in Q1 2023. 135 funds tracked by Wall St. Rank hold PLRX as of Q1 2024.

  • Landscape Capital Management reported no remaining Pliant Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Landscape Capital Management sold 16,146 Pliant Therapeutics shares in Q1 2024, an estimated $292K.
  • Landscape Capital Management first reported a position in Pliant Therapeutics in Q4 2022 and held it in 3 quarters.
  • Landscape Capital Management's Pliant Therapeutics position peaked at $551K in Q1 2023.
  • 135 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2024.

Based on Landscape Capital Management's 13F filing for Q1 2024, filed 9 May 2024.